Testing a new treatment for Alzheimer's disease
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
['FUNDING_OTHER'] · AUBURN UNIVERSITY AT AUBURN · NIH-10985011
This study is testing a new treatment called AU403 for Alzheimer's disease to see if it can help improve symptoms or slow down the disease, and it's designed for people living with Alzheimer's who are looking for new options.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AUBURN UNIVERSITY AT AUBURN (nih funded) |
| Locations | 1 site (Auburn, UNITED STATES) |
| Trial ID | NIH-10985011 on ClinicalTrials.gov |
What this research studies
This research investigates a novel treatment for Alzheimer's disease using a specific compound called AU403, which targets certain receptors in the body to potentially reduce harmful effects associated with the disease. The study will assess how well AU403 works in the body, including its absorption and safety, through a series of laboratory tests and experiments. Patients may benefit from this research as it aims to develop a new therapy that could improve symptoms or slow the progression of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other forms of dementia not related to Alzheimer's may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new effective treatment option for patients with Alzheimer's disease.
How similar studies have performed: Other research has shown promise in targeting similar receptors for Alzheimer's treatment, suggesting potential for success with this approach.
Where this research is happening
Auburn, UNITED STATES
- AUBURN UNIVERSITY AT AUBURN — Auburn, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AMIN, RAJESH H — AUBURN UNIVERSITY AT AUBURN
- Study coordinator: AMIN, RAJESH H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.